Diagnosis and treatment of vascular damage in dementia

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1862, Issue 5, 2016, Pages 869-877

  Biessels, Geert Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Diagnostic criteria; Magnetic resonance imaging; Small vessel disease; Stroke; Vascular cognitive impairment; Vascular dementia

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BRAIN DAMAGE; BRAIN HEMORRHAGE; CLINICAL EVALUATION; COGNITION; COGNITIVE DEFECT; DEMENTIA; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIVASCULAR SPACE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); VASCULAR COGNITIVE IMPAIRMENT; VASCULAR LESION; WHITE MATTER LESION;

EID: 84949436803     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.11.009     Document Type: Article

References (65)

1. de Bruijn R.F., Bos M.J., Portegies M.L., Hofman A., Franco O.H., Koudstaal P.J., Ikram M.A. The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study. BMC. Med. 2015, 13:132.
2. Norton S., Matthews F.E., Barnes D.E., Yaffe K., Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol. 2014, 13:788-794.
3. Dichgans M., Zietemann V. Prevention of vascular cognitive impairment. Stroke 2012, 43:3137-3146.
4. Bath P.M., Wardlaw J.M. Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions. Int. J. Stroke 2015, 10:469-478.
5. Roman G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., Amaducci L., Orgogozo J.M., Brun A., Hofman A. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993, 43:250-260. (a.et).
6. Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992, 42:473-480.
7. American Psychiatric Association Committee on Nomenclature and Statistics Diagnostic and Statistical Manual of Mental Disorders (DSM-III) 1980, American Psychiatric Association, Washington DC.
8. Hachinski V. Vascular dementia: a radical redefinition. Dementia 1994, 5:130-132.
9. O'Brien J.T., Erkinjuntti T., Reisberg B., Roman G., Sawada T., Pantoni L., Bowler J.V., Ballard C., DeCarli C., Gorelick P.B., Rockwood K., Burns A., Gauthier S., DeKosky S.T. Vascular cognitive impairment. Lancet Neurol. 2003, 2:89-98.
10. Moorhouse P., Rockwood K. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol. 2008, 7:246-255.
11. Schneider J.A., Wilson R.S., Bienias J.L., Evans D.A., Bennett D.A. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 2004, 62:1148-1155.
12. Schneider J.A., Bennett D.A. Where vascular meets neurodegenerative disease. Stroke 2010, 41:S144-S146.
13. Gorelick P.B., Scuteri A., Black S.E., DeCarli C., Greenberg S.M., Iadecola C., Launer L.J., Laurent S., Lopez O.L., Nyenhuis D., Petersen R.C., Schneider J.A., Tzourio C., Arnett D.K., Bennett D.A., Chui H.C., Higashida R.T., Lindquist R., Nilsson P.M., Roman G.C., Sellke F.W., Seshadri S. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:2672-2713.
14. Sachdev P., Kalaria R., O'Brien J., Skoog I., Alladi S., Black S.E., Blacker D., Blazer D.G., Chen C., Chui H., Ganguli M., Jellinger K., Jeste D.V., Pasquier F., Paulsen J., Prins N., Rockwood K., Roman G., Scheltens P. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis. Assoc. Disord. 2014, 28:206-218.
15. Hachinski V. Shifts in thinking about dementia. JAMA 2008, 300:2172-2173.
16. Hachinski V., Iadecola C., Petersen R.C., Breteler M.M., Nyenhuis D.L., Black S.E., Powers W.J., DeCarli C., Merino J.G., Kalaria R.N., Vinters H.V., Holtzman D.M., Rosenberg G.A., Wallin A., Dichgans M., Marler J.R., Leblanc G.G. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006, 37:2220-2241.
17. Staekenborg S.S., Su T., van Straaten E.C., Lane R., Scheltens P., Barkhof F., van der Flier W.M. Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease. J. Neurol. Neurosurg. Psychiatry 2010, 81:547-551.
18. Thomas A.J., Kalaria R.N., O'Brien J.T. Depression and vascular disease: what is the relationship?. J. Affect. Disord. 2004, 79:81-95.
19. Adams H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., Marsh E.E. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
20. Qureshi A.I., Mendelow A.D., Hanley D.F. Intracerebral haemorrhage. Lancet 2009, 373:1632-1644.
21. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010, 9:689-701.
22. Wardlaw J.M., Smith C., Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013, 12:483-497.
23. Biessels G.J. Capitalising on modifiable risk factors for Alzheimer's disease. Lancet Neurol. 2014, 13:752-753.
24. Iadecola C. The pathobiology of vascular dementia. Neuron 2013, 80:844-866.
25. Snyder H.M., Corriveau R.A., Craft S., Faber J.E., Greenberg S.M., Knopman D., Lamb B.T., Montine T.J., Nedergaard M., Schaffer C.B., Schneider J.A., Wellington C., Wilcock D.M., Zipfel G.J., Zlokovic B., Bain L.J., Bosetti F., Galis Z.S., Koroshetz W., Carrillo M.C. Vascular contributions to cognitive impairment and dementia including Alzheimer's disease. Alzheimers Dement. 2015, 11:710-717.
26. Wardlaw J.M., Smith E.E., Biessels G.J., Cordonnier C., Fazekas F., Frayne R., Lindley R.I., O'Brien J.T., Barkhof F., Benavente O.R., Black S.E., Brayne C., Breteler M., Chabriat H., DeCarli C., de Leeuw F.E., Doubal F., Duering M., Fox N.C., Greenberg S., Hachinski V., Kilimann I., Mok V., van Oostenbrugge R.J., Pantoni L., Speck O., Stephan B.C., Teipel S., Viswanathan A., Werring D., Chen C., Smith C., van Buchem M.A., Norrving B., Gorelick P.B., Dichgans M. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013, 12:822-838.
27. Schmidt R., Schmidt H., Haybaeck J., Loitfelder M., Weis S., Cavalieri M., Seiler S., Enzinger C., Ropele S., Erkinjuntti T., Pantoni L., Scheltens P., Fazekas F., Jellinger K. Heterogeneity in age-related white matter changes. Acta Neuropathol. 2011, 122:171-185.
28. Barkhof F., Scheltens P. Imaging of white matter lesions. Cerebrovasc. Dis. 2002, 13(Suppl 2):21-30.
29. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman R.A. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging, AJR. Am. J. Roentgenol. 1987, 149:351-356.
30. Greenberg S.M., Vernooij M.W., Cordonnier C., Viswanathan A., Al-Shahi Salman R., Warach S., Launer L.J., van Buchem M.A., Breteler M.M. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009, 8:165-174.
31. Gouw A.A., Seewann A., van der Flier W.M., Barkhof F., Rozemuller A.M., Scheltens P., Geurts J.J. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J. Neurol. Neurosurg. Psychiatry 2011, 82:126-135.
32. Rosenberg G.A., Wallin A., Wardlaw J.M., Markus H.S., Montaner J., Wolfson L., Iadecola C., Zlokovic B.V., Joutel A., Dichgans M., Duering M., Schmidt R., Korczyn A.D., Grinberg L.T., Chui H.C., Hachinski V. Consensus Statement for Diagnosis of Subcortical Small Vessel Disease. J. Cereb. Blood Flow Metab. 2015.
33. Haffner C., Malik R., Dichgans M. Genetic Factors in Cerebral Small Vessel Disease and Their Impact on Stroke and Dementia 2015.
34. Vermeer S.E., Longstreth W.T., Koudstaal P.J. Silent brain infarcts: a systematic review. Lancet Neurol. 2007, 6:611-619.
35. de Leeuw F.E., de Groot J.C., Achten E., Oudkerk M., Ramos L.M., Heijboer R., Hofman A., Jolles J., van Gijn J., Breteler M.M. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J. Neurol. Neurosurg. Psychiatry 2001, 70:9-14..
36. Duering M., Zieren N., Herve D., Jouvent E., Reyes S., Peters N., Pachai C., Opherk C., Chabriat H., Dichgans M. Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL. Brain 2011, 134:2366-2375.
37. Biesbroek J.M., Kuijf H.J., van der Graaf Y., Vincken K.L., Postma A., Mali W.P., Biessels G.J., Geerlings M.I. Association between subcortical vascular lesion location and cognition: a voxel-based and tract-based lesion-symptom mapping study. The SMART-MR Study. PLoS ONE 2013, 8:e60541.
38. de Groot M., Ikram M.A., Akoudad S., Krestin G.P., Hofman A., van der Lugt A., Niessen W.J., Vernooij M.W. Tract-specific white matter degeneration in aging: the Rotterdam Study. Alzheimers. Dement. 2015, 11:321-330.
39. Pendlebury S.T., Rothwell P.M. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009, 8:1006-1018.
40. Nys G.M., Van Zandvoort M.J., de Kort P.L., van der Worp H.B., Jansen B.P., Algra A., De Haan E.H., Kappelle L.J. The prognostic value of domain-specific cognitive abilities in acute first-ever stroke. Neurology 2005, 64:821-827.
41. Yang J., Wong A., Wang Z., Liu W., Au L., Xiong Y., Chu W.W., Leung E.Y., Chen S., Lau C., Chan A.Y., Lau A.Y., Fan F., Ip V., Soo Y., Leung T., Ho C.L., Wong L.K., Mok V.C. Risk factors for incident dementia after stroke and transient ischemic attack. Alzheimers Dement. 2015, 11:16-23.
42. Kernan W.N., Ovbiagele B., Black H.R., Bravata D.M., Chimowitz M.I., Ezekowitz M.D., Fang M.C., Fisher M., Furie K.L., Heck D.V., Johnston S.C., Kasner S.E., Kittner S.J., Mitchell P.H., Rich M.W., Richardson D., Schwamm L.H., Wilson J.A. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014, 45:2160-2236.
43. Prins N.D., Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat. Rev. Neurol. 2015, 11:157-165.
44. Chui H.C., Ramirez-Gomez L. Clinical and imaging features of mixed Alzheimer and vascular pathologies. Alzheimers Res. Ther. 2015, 7:21.
45. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS), Lancet 357 2001, 169-175.
46. Schneider J.A., Arvanitakis Z., Bang W., Bennett D.A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007, 69:2197-2204.
47. Staekenborg S.S., Koedam E.L., Henneman W.J., Stokman P., Barkhof F., Scheltens P., van der Flier W.M. Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy. Stroke 2009, 40:1269-1274.
48. van de Pol L.A., Korf E.S., van der Flier W.M., Brashear H.R., Fox N.C., Barkhof F., Scheltens P. Magnetic resonance imaging predictors of cognition in mild cognitive impairment. Arch. Neurol. 2007, 64:1023-1028.
49. DeCarli C., Mungas D., Harvey D., Reed B., Weiner M., Chui H., Jagust W. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology 2004, 63:220-227.
50. Baezner H., Blahak C., Poggesi A., Pantoni L., Inzitari D., Chabriat H., Erkinjuntti T., Fazekas F., Ferro J.M., Langhorne P., O'Brien J., Scheltens P., Visser M.C., Wahlund L.O., Waldemar G., Wallin A., Hennerici M.G. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 2008, 70:935-942.
51. van der Vlies A.E., Goos J.D., Barkhof F., Scheltens P., van der Flier W.M. Microbleeds do not affect rate of cognitive decline in Alzheimer disease. Neurology 2012, 79:763-769.
52. Henneman W.J., Sluimer J.D., Cordonnier C., Baak M.M., Scheltens P., Barkhof F., van der Flier W.M. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population. Stroke 2009, 40:492-498.
53. Benedictus M.R., Prins N.D., Goos J.D., Scheltens P., Barkhof F., van der Flier W.M. Microbleeds, Mortality, and Stroke in Alzheimer Disease: The MISTRAL Study. JAMA Neurol. 2015, 72:539-545.
54. Richard E., Kuiper R., Dijkgraaf M.G., van Gool W.A. Vascular care in patients with Alzheimer's disease with cerebrovascular lesions-a randomized clinical trial. J. Am. Geriatr. Soc. 2009, 57:797-805.
55. Richard E., Gouw A.A., Scheltens P., van Gool W.A. Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI: the evaluation of vascular care in Alzheimer's disease (EVA) study. Stroke 2010, 41:554-556.
56. Thoonsen H., Richard E., Bentham P., Gray R., van G.N., de Haan R.J., van Gool W.A., Nederkoorn P.J. Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern?. Stroke 2010, 41:2690-2692.
57. Lip G.Y., Nieuwlaat R., Pisters R., Lane D.A., Crijns H.J. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010, 137:263-272.
58. Ruff C.T., Giugliano R.P., Braunwald E., Hoffman E.B., Deenadayalu N., Ezekowitz M.D., Camm A.J., Weitz J.I., Lewis B.S., Parkhomenko A., Yamashita T., Antman E.M. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014, 383:955-962.
59. Joutel A., Haddad I., Ratelade J., Nelson M.T. Perturbations of the cerebrovascular matrisome: a convergent mechanism in small vessel disease of the brain?. J. Cereb. Blood Flow Metab. 2015.
60. Dabertrand F., Kroigaard C., Bonev A.D., Cognat E., Dalsgaard T., Domenga-Denier V., Hill-Eubanks D.C., Brayden J.E., Joutel A., Nelson M.T. Potassium channelopathy-like defect underlies early-stage cerebrovascular dysfunction in a genetic model of small vessel disease. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:E796-E805.
61. Lobo A., Launer L.J., Fratiglioni L., Andersen K., Di Carlo A., Breteler M.M., Copeland J.R., Dartigues J.F., Jagger C., Martinez-Lage J., Soininen H., Hofman A. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000, 54:S4-S9.
62. Jack C.R., Knopman D.S., Jagust W.J., Petersen R.C., Weiner M.W., Aisen P.S., Shaw L.M., Vemuri P., Wiste H.J., Weigand S.D., Lesnick T.G., Pankratz V.S., Donohue M.C., Trojanowski J.Q. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013, 12:207-216.
63. Bouvy W.H., Geurts L.J., Kuijf H.J., Luijten P.R., Kappelle L.J., Biessels G.J., Zwanenburg J.J. Assessment of blood flow velocity and pulsatility in cerebral perforating arteries with 7-T quantitative flow MRI. NMR Biomed. 2015.
64. Siero J.C., Hartkamp N.S., Donahue M.J., Harteveld A.A., Compter A., Petersen E.T., Hendrikse J. Neuronal activation induced BOLD and CBF responses upon acetazolamide administration in patients with steno-occlusive artery disease. NeuroImage 2015, 105:276-285.
65. Bhogal A.A., Philippens M.E., Siero J.C., Fisher J.A., Petersen E.T., Luijten P.R., Hoogduin H. Examining the regional and cerebral depth-dependent BOLD cerebrovascular reactivity response at 7 T. NeuroImage 2015, 114:239-248.